文献速递腹部CTMR

光子计数CT与MRI在直肠癌中的再评估:标准化碘浓度与表观扩散系数的扩大队列研究

Photon-counting computed tomography and magnetic resonance imaging in rectal cancer: reassessment of normalized iodine concentration and apparent diffusion coefficient in an expanded cohort.
PubMed 文献 · Abdom Radiol (NY) · 2026-10-17

本研究在63例直肠腺癌患者中重新评估术前光子计数CT衍生的标准化碘浓度(NIC)对组织病理学治疗反应的预测价值,并以MRI衍生的表观扩散系数(ADC)作为队列内参考标志物。结果显示,ADC在反应不良组显著较低(AUC 0.738),而NIC无组间差异(AUC 0.509),先前报道的NIC阈值≥0.36未再现高性能,且NIC加入ADC未改善模型拟合。

要点

  • 术前ADC较低与Dworak 0-1级反应不良相关,可作为参考标志物。
  • NIC在反应不良与中/好反应组间无显著差异,未再现先前高性能。
  • 先前NIC阈值≥0.36的敏感度53.7%、特异度63.6%、准确率57.1%。
英文原文(摘要)· 点击展开

OBJECTIVES: To reassess pretreatment photon-counting computed tomography (PCCT)-derived normalized iodine concentration (NIC) in an expanded rectal-cancer cohort, using magnetic resonance imaging (MRI)-derived apparent diffusion coefficient (ADC) as a within-cohort reference marker for histopathologic treatment response.

METHODS: This single-center retrospective study included 63 patients with rectal adenocarcinoma who underwent pretreatment pelvic MRI and contrast-enhanced PCCT, followed by neoadjuvant treatment and surgical resection. Dworak tumor regression grades 0-1 were classified as poor response (n = 22) and grades 2-4 as moderate/good response (n = 41). MRI and PCCT were performed a median of 3 days apart (IQR, 1-4.5). The previously reported NIC threshold of ≥ 0.36 was reassessed without re-optimization. Twenty-one of 63 patients overlapped with the preceding pilot cohort; therefore, the present study is an expanded reassessment rather than an independent external validation.

RESULTS: Twenty-two patients showed poor response and 41 moderate/good response. ADC interobserver agreement was excellent (ICC, 0.959; 95% confidence interval [CI], 0.90-0.98). In the 61 patients with paired numeric NIC measurements from both observers, NIC interobserver agreement was also excellent (ICC, 0.905; bootstrap 95% CI, 0.858-0.936). Mean ADC was lower in poor responders than in moderate/good responders (0.876 ± 0.186 vs. 1.035 ± 0.208 × 10⁻³ mm²/s; p = 0.003; AUC, 0.738; 95% CI, 0.608-0.867). NIC did not differ between groups (median, 0.313 vs. 0.370; p = 0.91; AUC, 0.509; 95% CI, 0.362-0.656). Applying the previously published NIC threshold ≥ 0.36 yielded sensitivity 53.7%, specificity 63.6%, and accuracy 57.1% for Dworak grades 2-4. Adding NIC to ADC did not improve model fit (likelihood-ratio p = 0.601).

CONCLUSION: In this exploratory expanded cohort, lower pretreatment ADC was associated with Dworak grades 0-1. Single-phase portal-venous NIC measured with the described two-dimensional ROI approach did not reproduce the high performance reported in the pilot study and showed no evidence of improved model fit beyond ADC in this cohort. These findings require independent prospective validation.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Saeed S, Shahzadi I, Niehoff JH, et al. Photon-counting computed tomography and magnetic resonance imaging in rectal cancer: reassessment of normalized iodine concentration and apparent diffusion coefficient in an expanded cohort. Abdom Radiol (NY). 2026. PMID: 42891705. doi:10.1007/s00261-026-05831-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。